Skip to main content
. 2021 Nov 11;4(4):381–390. doi: 10.3138/canlivj-2021-0016

Table 3:

Adjusted hazard of developing selected outcomes during follow-up among C282Y homozygotes, compared with wild-type patients

Adjusted* hazard ratio (95% CI)
HR Lower CL Upper CL p-value
All-cause death 1.436 1.182 1.745 0.0003
Liver cancer 8.297 3.97 17.341 <0.001
Knee or hip joint replacement 3.063 2.461 3.811 <0.001
Diabetes 0.844 0.667 1.067 0.1567
Cirrhosis 3.872 3.047 4.920 <0.001
Osteoarthritis 1.719 1.472 2.007 <0.001

* Adjusted for age and sex